Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-16454

Zimmerli, L U; Schiffer, E; Zürbig, P; Good, D M; Kellmann, M; Mouls, L; Pitt, A R; Coon, J J; Schmieder, R E; Peter, K H; Mischak, H; Kolch, W; Delles, C; Dominiczak, A F (2008). Urinary proteomic biomarkers in coronary artery disease. Molecular & Cellular Proteomics, 7(2):290-298.

[img] PDF - Registered users only
1MB

View at publisher
[img]
Preview
Accepted Version
PDF
1MB

Abstract

Urinary proteomics is emerging as a powerful non-invasive tool for diagnosis and monitoring of variety of human diseases. We tested whether signatures of urinary polypeptides can contribute to the existing biomarkers for coronary artery disease (CAD). We examined a total of 359 urine samples from 88 patients with severe CAD and 282 controls. Spot urine was analyzed using capillary electrophoresis on-line coupled to ESI-TOF-MS enabling characterization of more than 1000 polypeptides per sample. In a first step a "training set" for biomarker definition was created. Multiple biomarker patterns clearly distinguished healthy controls from CAD patients, and we extracted 15 peptides that define a characteristic CAD signature panel. In a second step, the ability of the CAD-specific panel to predict the presence of CAD was evaluated in a blinded study using a "test set." The signature panel showed sensitivity of 98% (95% confidence interval, 88.7-99.6) and 83% specificity (95% confidence interval, 51.6-97.4). Furthermore the peptide pattern significantly changed toward the healthy signature correlating with the level of physical activity after therapeutic intervention. Our results show that urinary proteomics can identify CAD patients with high confidence and might also play a role in monitoring the effects of therapeutic interventions. The workflow is amenable to clinical routine testing suggesting that non-invasive proteomics analysis can become a valuable addition to other biomarkers used in cardiovascular risk assessment.

Citations

96 citations in Web of Science®
110 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 24 Feb 2009
24 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic and Policlinic for Internal Medicine
DDC:610 Medicine & health
Language:English
Date:6 February 2008
Deposited On:24 Feb 2009 17:02
Last Modified:27 Nov 2013 19:51
Publisher:American Society for Biochemistry and Molecular Biology
ISSN:1535-9476
Additional Information:This research was originally published in Zimmerli, L U; Schiffer, E; Zürbig, P; Good, D M; Kellmann, M; Mouls, L; Pitt, A R; Coon, J J; Schmieder, R E; Peter, K H; Mischak, H; Kolch, W; Delles, C; Dominiczak, A F (2008). Urinary proteomic biomarkers in coronary artery disease. Molecular & Cellular Proteomics, 7(2):290-298. © the American Society for Biochemistry and Molecular Biology.
Publisher DOI:10.1074/mcp.M700394-MCP200
PubMed ID:17951555

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page